These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31353759)

  • 1. Clinical and brain structural effects of the Illness Management and Recovery program in middle-aged and older patients with schizophrenia.
    Nakamura R; Asami T; Yoshimi A; Kato D; Fujita E; Takaishi M; Yoshida H; Yamaguchi H; Shiozaki K; Kase A; Hirayasu Y
    Psychiatry Clin Neurosci; 2019 Dec; 73(12):731-737. PubMed ID: 31353759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of an adapted Illness Management and Recovery program for people with schizophrenia awaiting discharge from a psychiatric hospital.
    Lin EC; Chan CH; Shao WC; Lin MF; Shiau S; Mueser KT; Huang SC; Wang HS
    Psychiatr Rehabil J; 2013 Dec; 36(4):243-9. PubMed ID: 24320832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium.
    Walton E; Hibar DP; van Erp TG; Potkin SG; Roiz-Santiañez R; Crespo-Facorro B; Suarez-Pinilla P; Van Haren NE; de Zwarte SM; Kahn RS; Cahn W; Doan NT; Jørgensen KN; Gurholt TP; Agartz I; Andreassen OA; Westlye LT; Melle I; Berg AO; Mørch-Johnsen L; Faerden A; Flyckt L; Fatouros-Bergman H; ; Jönsson EG; Hashimoto R; Yamamori H; Fukunaga M; Preda A; De Rossi P; Piras F; Banaj N; Ciullo V; Spalletta G; Gur RE; Gur RC; Wolf DH; Satterthwaite TD; Beard LM; Sommer IE; Koops S; Gruber O; Richter A; Krämer B; Kelly S; Donohoe G; McDonald C; Cannon DM; Corvin A; Gill M; Di Giorgio A; Bertolino A; Lawrie S; Nickson T; Whalley HC; Neilson E; Calhoun VD; Thompson PM; Turner JA; Ehrlich S
    Acta Psychiatr Scand; 2017 May; 135(5):439-447. PubMed ID: 28369804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study.
    Chou PH; Koike S; Nishimura Y; Kawasaki S; Satomura Y; Kinoshita A; Takizawa R; Kasai K
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():63-9. PubMed ID: 24275075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of the illness management and recovery program for persons with schizophrenia.
    Färdig R; Lewander T; Melin L; Folke F; Fredriksson A
    Psychiatr Serv; 2011 Jun; 62(6):606-12. PubMed ID: 21632728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive functioning and outcome of the Illness Management and Recovery Program for clients with schizophrenia and schizoaffective disorder.
    Färdig R; Fredriksson A; Lewander T; Melin L; Mueser KT
    Nord J Psychiatry; 2016 Aug; 70(6):430-5. PubMed ID: 26936087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Randomized controlled trial on effectiveness of the community re-entry program to inpatients with schizophrenia spectrum disorder, centering around acquisition of illness self-management knowledge].
    Naoki K; Nobuo A; Emi I
    Seishin Shinkeigaku Zasshi; 2003; 105(12):1514-31. PubMed ID: 15027310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of an illness management and recovery program in discharged patients with schizophrenia.
    Lin EC; Shao WC; Chan CH; Shiau S; Wang HS; Huang SC
    J Nurs Res; 2013 Dec; 21(4):270-7. PubMed ID: 24241276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphology of the lateral superior temporal gyrus in neuroleptic nai;ve patients with schizophrenia: relationship to symptoms.
    Kim JJ; Crespo-Facorro B; Andreasen NC; O'Leary DS; Magnotta V; Nopoulos P
    Schizophr Res; 2003 Apr; 60(2-3):173-81. PubMed ID: 12591581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing Illness Management and Recovery Within Assertive Community Treatment: A Pilot Trial of Feasibility and Effectiveness.
    Monroe-DeVita M; Morse G; Mueser KT; McHugo GJ; Xie H; Hallgren KA; Peterson R; Miller J; Akiba C; York M; Gingerich S; Stiles B
    Psychiatr Serv; 2018 May; 69(5):562-571. PubMed ID: 29446335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illness management and recovery: one-year follow-up of a randomized controlled trial in Danish community mental health centers: long-term effects on clinical and personal recovery.
    Jensen SB; Dalum HS; Korsbek L; Hjorthøj C; Mikkelsen JH; Thomsen K; Kistrup K; Olander M; Lindschou J; Mueser KT; Nordentoft M; Eplov LF
    BMC Psychiatry; 2019 Feb; 19(1):65. PubMed ID: 30744590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic alterations of the parcellated superior temporal gyrus in schizophrenia spectrum.
    Takahashi T; Suzuki M; Zhou SY; Tanino R; Hagino H; Kawasaki Y; Matsui M; Seto H; Kurachi M
    Schizophr Res; 2006 Apr; 83(2-3):131-43. PubMed ID: 16503399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of illness management and recovery (IMR) in the Netherlands: a randomised clinical trial.
    Roosenschoon BJ; Mulder CL; Deen ML; van Weeghel J
    BMC Psychiatry; 2016 Mar; 16():73. PubMed ID: 26995361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia.
    Takahashi T; Suzuki M; Zhou SY; Tanino R; Nakamura K; Kawasaki Y; Seto H; Kurachi M
    Schizophr Res; 2010 Jun; 119(1-3):65-74. PubMed ID: 20051316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia.
    Zhang W; Deng W; Yao L; Xiao Y; Li F; Liu J; Sweeney JA; Lui S; Gong Q
    Am J Psychiatry; 2015 Oct; 172(10):995-1003. PubMed ID: 26085040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of lateral temporal cortical gray matter and facial memory as vulnerability indicators for schizophrenia: An MRI study in youth at familial high-risk for schizophrenia.
    Brent BK; Rosso IM; Thermenos HW; Holt DJ; Faraone SV; Makris N; Tsuang MT; Seidman LJ
    Schizophr Res; 2016 Jan; 170(1):123-9. PubMed ID: 26621001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study.
    Shenton ME; Kikinis R; Jolesz FA; Pollak SD; LeMay M; Wible CG; Hokama H; Martin J; Metcalf D; Coleman M
    N Engl J Med; 1992 Aug; 327(9):604-12. PubMed ID: 1640954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural alterations of the superior temporal gyrus in schizophrenia: Detailed subregional differences.
    Ohi K; Matsuda Y; Shimada T; Yasuyama T; Oshima K; Sawai K; Kihara H; Nitta Y; Okubo H; Uehara T; Kawasaki Y
    Eur Psychiatry; 2016 May; 35():25-31. PubMed ID: 27061374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.